Canadian OTC Ophthalmology Products Market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around XX% during the forecast period (2019-2028)

In Canada, the leading cause of visual impairment is glaucoma, diabetic retinopathy, degenerative myopia, age-related macular degeneration, and cataract. In addition, according to the Global Health Data Exchange, the prevalence of age-related macular degeneration is around 18,644 in 2018. The number is estimated to grow by 19,252 in 2019. Hence, the rising prevalence of eye disorders will lead to the growing demand for OTC Ophthalmology Products Market.



Market Driving Factors

An increasing number of people suffering from diabetes and glaucoma, Elderly population, urban residence, low socio-economic affluence, increasing incidence of vision impairment, high innovation, and heavy funding in the development of combination therapies are the major factors driving the growth of this market. Consistent advancements in medical technology, such as introducing innovative products that are more scalable and effective in care, are propelling the Canadian OTC Ophthalmology Products Market growth. Apart from that, the ophthalmic market's ability to expand is severely hampered by the high cost of ophthalmic instruments utilized for diagnostic purposes.

Major Ophthalmology Diseases

The major ophthalmology diseases are Glaucoma, Dry eye syndrome, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related macular degeneration, Macular Edema and Allergic Conjunctivitis. Glaucoma is the largest indication segment, followed by Age-Related Macular Degeneration.